Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |